A campaign against Alzheimer's disease

2012-05-25 15:59

分享到

 

Get Flash Player

Download

This is the VOA Special English Health Report.

Last week, the United States government announced a major education and research campaign against Alzheimer's disease. The brain-wasting disease has no cure. The plan includes more efforts to develop drugs to prevent it.

In the United States, more than five million people have Alzheimer's or some other form of dementia. As the population gets older, the number is expected to reach almost eight million by 2030. By then, experts say Alzheimer's and other dementia disorders could affect as many as 66 million people worldwide.

A campaign against Alzheimer's disease

The national Alzheimer's plan calls on scientists to develop treatments to prevent the disease by 2025. Officials at the National Institutes of Health have promised 50 million dollars to help support that effort. NIH held a conference of the nation's top Alzheimer's researchers where NIH Director Francis Collins discussed the plan.

FRANCIS COLLINS: "We have learned more about this disease in the last couple of years than probably ever before. And now the goal is to take that and translate it into interventions."

Early next year, scientists at the Banner Alzheimer's Institute in Arizona plan to begin human testing of an experimental drug. The drug is called crenezumab, and the hope is it will prevent Alzheimer's.

The study will involve members of a large extended family living in villages in the Medellin area in Colombia. Some of the family members have a rare genetic disorder that causes them to get early-onset Alzheimer's. They begin to show signs of mental loss in their mid-40s and fully develop the disease by their early 50s.

Three hundred people have agreed to be in the study. One-third of them will receive crenezumab. The others will be given a placebo, a pill that does not contain any drug. They will not know if they have been given the drug or the placebo. The study will also include a smaller number of people in the United States.

Pierre Tariot will help lead the study, known as a human trial. He says all of the people have been informed that the drug might not work or that they might receive a placebo. Mr. Tariot says the people still wanted to be in the study.

PIERRE TARIOT: "They have been faced with this devastating illness hitting every generation for hundreds of years. As one of them put it, 'There are many rivers to cross but at least we're at the first bank.' And that's kind of the attitude that people have had."

Scientists hope that if the drug works in those facing early-onset Alzheimer's, then it might also help older people.

The study in Colombia could take as long as five years, but researchers believe they could get results in two years.

And that's the VOA Special English Health Report. You can learn more about Alzheimer's disease and find a link to the national plan at voaspecialenglish.com. I'm Faith Lapidus.

Related stories:

90岁以上高龄女性比男性更易患痴呆症

肥胖病人多伴有严重脑衰退

A possible blood test for Alzheimer's disease

The struggle for a dependable test for Alzheimer's disease

(来源:VOA 编辑:旭燕)

 

分享到

中国日报网英语点津版权说明:凡注明来源为“中国日报网英语点津:XXX(署名)”的原创作品,除与中国日报网签署英语点津内容授权协议的网站外,其他任何网站或单位未经允许不得非法盗链、转载和使用,违者必究。如需使用,请与010-84883561联系;凡本网注明“来源:XXX(非英语点津)”的作品,均转载自其它媒体,目的在于传播更多信息,其他媒体如需转载,请与稿件来源方联系,如产生任何问题与本网无关;本网所发布的歌曲、电影片段,版权归原作者所有,仅供学习与研究,如果侵权,请提供版权证明,以便尽快删除。

中国日报网双语新闻

扫描左侧二维码

添加Chinadaily_Mobile
你想看的我们这儿都有!

中国日报双语手机报

点击左侧图标查看订阅方式

中国首份双语手机报
学英语看资讯一个都不能少!

关注和订阅

本文相关阅读
人气排行
搜热词
 
 
精华栏目
 

阅读

词汇

视听

翻译

口语

合作

 

关于我们 | 联系方式 | 招聘信息

Copyright by chinadaily.com.cn. All rights reserved. None of this material may be used for any commercial or public use. Reproduction in whole or in part without permission is prohibited. 版权声明:本网站所刊登的中国日报网英语点津内容,版权属中国日报网所有,未经协议授权,禁止下载使用。 欢迎愿意与本网站合作的单位或个人与我们联系。

电话:8610-84883645

传真:8610-84883500

Email: languagetips@chinadaily.com.cn